Mirati Therapeutics, Inc.

US BANCORP \DE\

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/9/2024

Shares

3,545

Value ($000)

208

Weight

0.0%

2019 Q4 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/9/2024	208	0.0%	3,545	12/31/2023
2023 Q3	11/3/2023	147	0.0%	3,367	9/30/2023
2023 Q2	8/10/2023	40	0.0%	1,095	6/30/2023
2023 Q1	5/9/2023	106	0.0%	2,855	3/31/2023
2022 Q4	2/13/2023	83	0.0%	1,841	12/31/2022
2022 Q3	10/27/2022	275	0.0%	3,938	9/30/2022
2022 Q2	8/1/2022	227	0.0%	3,369	6/30/2022
2022 Q1	5/11/2022	156	0.0%	1,898	3/31/2022
2021 Q4	2/11/2022	63	0.0%	420	12/31/2021
2021 Q3	11/10/2021	86	0.0%	488	9/30/2021
2021 Q2	8/5/2021	44	0.0%	272	6/30/2021
2021 Q1	4/28/2021	27	0.0%	157	3/31/2021
2020 Q4	2/4/2021	19	0.0%	85	12/31/2020
2020 Q3	11/10/2020	2	0.0%	13	9/30/2020
2019 Q4	2/4/2020	6	0.0%	44	12/31/2019